India’s healthcare sector is beginning to feel the indirect effects of the ongoing conflict involving Iran, with industry experts warning that prolonged geopolitical tensions could eventually lead to higher medical costs for patients. While there has been no immediate disruption to routine healthcare services, supply chain pressures are steadily building, raising concerns across the pharmaceutical and medical devices industries.

India relies heavily on imports for raw materials, active pharmaceutical ingredients (APIs), and specialised components used in medicines and medical equipment. Disruptions in critical global shipping routes, particularly the Strait of Hormuz, along with rising energy prices, have increased freight costs and delayed shipments. Manufacturers of essential items such as syringes, gloves, and catheters are already reporting longer lead times and elevated input costs, even though widespread shortages have not yet materialised.

Healthcare professionals say the current impact remains largely contained due to existing inventory buffers. However, they caution that sustained disruptions could eventually translate into higher patient bills. Rohan Palshetkar, an IVF specialist, noted that while day-to-day services remain unaffected, continued reliance on imported materials and equipment may push procurement costs higher. This, in turn, could lead to increased treatment expenses if the situation persists.

Also Read: Australia Establishes Fuel Task Force as ACCC Investigates Supply Chain Concerns

Industry leaders have echoed similar concerns about the pharmaceutical sector, which depends significantly on imported APIs and petrochemical-based inputs. Rising costs of medical-grade plastics, packaging, and fuel are adding pressure to production expenses. Some estimates suggest that prices of key materials have surged sharply in recent months, forcing companies to consider selective price adjustments, especially in areas with high import dependence.

The ripple effects are also being felt in adjacent sectors such as nutraceuticals and medical tourism. Delays in shipments, higher packaging costs, and stable demand are stretching production timelines for supplements, while patients seeking treatment in India are increasingly postponing travel plans amid regional uncertainty. Despite this, India’s healthcare infrastructure and clinical expertise continue to attract international patients, who are expected to resume travel once conditions stabilise.

Experts warn that if disruptions to global trade routes continue, patients in India could face a gradual rise in healthcare costs, longer waiting times for certain treatments, and reduced availability of some imported medical components. While companies are currently absorbing a portion of the increased costs, prolonged instability may make it difficult to shield consumers, ultimately impacting affordability and access to care.

Also Read: Energy Minister Confirms Disruptions in Bangladesh Fuel Supply Due to Increased Demand